Search
By assuming primitive regenerative identities, cancer cells gain the adaptability they need to establish tumors in new parts of the body.
Research led by investigators at Memorial Sloan Kettering has identified a previously unknown mechanism of resistance to the newly approved melanoma drug, vemurafenib.
Immunologist Alexander Rudensky and medical oncologist and immunologist Jedd Wolchok are investigating innovative ways to use the immune system to fight cancer.
A multidisciplinary team at Memorial Sloan Kettering Cancer Center (MSK) has developed a proof-of-concept crisis ventilator intended to provide lifesaving breathing assistance to patients requiring it when more-sophisticated respiratory support equipment is unavailable.
GSK students, alumni, faculty, and guest speakers enjoyed two days of presentations, panel discussions, a poster session, recreation and socializing at the school’s fourth biennial retreat.
Medical oncologist Chau Dang explains that patients living with metastatic breast cancer have more treatment options than ever before.
Simon Powell leads the Department of Radiation Oncology and focuses in his research on the treatment of breast cancer, including the role of DNA repair deficiencies in breast cancer and breast cancer genetics.
MSK is a founding member of Break Through Cancer, a newly launched foundation aimed at accelerating collaborative research, clinical trials, and cures for the deadliest cancers.
A Memorial Sloan Kettering Cancer Center study suggests that a new, experimental treatment could make bone marrow and stem cell transplantation more effective and safe.
TV anchor Al Roker discusses his own prostate cancer experiences, disparities in cancer care and outcomes for people of color, the importance of cancer screening for Black men, and more with Dr. Carol Brown, a gynecological oncology surgeon at Memorial Sloan Kettering and Nicholls-Biondi Chair for Health Equity at Memorial Sloan Kettering.